About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Portland | 441 Studies

Clinical Trials Breast CancerPortland

Breast Cancer Clinical Trials in Portland

Find 441 clinical trials for breast cancer near Portland, Oregon. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Portland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 161-180 of 441 trials

CompletedTrial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast CancerThis randomized, double blind, placebo controlled trial will evaluate the impact of adding everolimus to the combination of weekly paclitaxel plus bevacizumab in the first-line…NCT00915603·LaVerne, California and 14 others CompletedZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementThis randomized phase III trial studies two different schedules of zoledronic acid to compare how well they work in reducing bone-related complications in patients with breast…NCT00869206·Fairbanks, Alaska and 503 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPhase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast CancerDose Escalation part of the study: To estimate the MTD(s) and/ or RP2D of LEE011 in combination with everolimus + exemestane, and LEE011 in combination with exemestane, and to…NCT01857193·Fayetteville, Arkansas and 12 others

RecruitingBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaThis study is a multiple cohort, multicenter, open-label Phase 1 study with dose-escalation substudies investigating intravenous (IV) BAL0891 as monotherapy, and in combination…NCT05768932·New Haven, Connecticut and 16 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)This Phase II, randomized, open-label, multicenter study will evaluate the efficacy and safety of giredestrant compared with physician's choice of endocrine monotherapy in…NCT04576455·Marietta, Georgia and 80 others

CompletedPhase 3 Randomized Placebo Controlled Clinical Trial of DonepezilThis study is to compare the safety and effects of donepezil (Aricept) for patients reporting cognitive or memory issues after receiving chemotherapy for breast cancer.NCT02822573·Anaheim, California and 277 others

Active not recruitingA Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)This is an open-label, first-in-human study designed to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity of selpercatinib (also known…NCT03157128·Scottsdale, Arizona and 84 others

CompletedS0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With ChemoRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00382018·Anniston, Alabama and 295 others

Approved for marketingEAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast CancerThis study will provide pre-approval drug access to lapatinib, in combination with capecitabine, to patients whose breast cancer had progressed on other therapiesNCT00338247·Huntsville, Alabama and 452 others

RecruitingNeoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC PatientsThis is a Phase II trial to assess efficacy and feasibility of pembrolizumab + INBRX-106 as an induction therapy preceding neoadjuvant therapy.NCT06353997·Los Angeles, California and 2 others

RecruitingRinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors.NCT05579366·Phoenix, Arizona and 65 others

Active not recruitingPembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast CancerThis is a Phase II, randomized, open-label trial to evaluate the clinical and immunologic activity of pembrolizumab plus chemotherapy when combined with various immunotherapy…NCT04373031·Portland, Oregon

CompletedStudy of Pralatrexate in Female Patients With Previously-treated Breast CancerThe purpose of this study is to determine the efficacy (ability to provide a beneficial treatment of the disease) of pralatrexate for the treatment of female patients with…NCT01118624·Portland, Oregon and 13 others

CompletedTamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells.NCT01124695·Birmingham, Alabama and 293 others

CompletedBroccoli Sprout Extract in Treating Women Who Have Had a Mammogram and Breast BiopsyRATIONALE: Broccoli sprout extract supplements may slow the growth of tumor cells or abnormal cells and may be an effective treatment for ductal carcinoma in situ and/or atypical…NCT00843167·Portland, Oregon

CompletedExercise Information for Women With CancerFatigue is a troublesome symptom for breast cancer patients, which might be mitigated with exercise.NCT03120819·Portland, Oregon

CompletedIrinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy, such as irinotecan and docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00079118·Scottsdale, Arizona and 161 others

Active not recruitingTesting Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainThis phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer…NCT06500455·Tucson, Arizona and 269 others

CompletedA Safety Study of SGN-LIV1A in Breast Cancer PatientsThis study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer.NCT01969643·Birmingham, Alabama and 37 others

CompletedA Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE)This 2-arm, randomized, open-label study will evaluate the efficacy and safety of trastuzumab emtansine versus trastuzumab as adjuvant therapy in patients with HER2-positive…NCT01772472·Anchorage, Alaska and 267 others

PreviousPage 9 of 23Next

Other Conditions in Portland

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma